thiazolyl blue has been researched along with Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalonia, H; Kumar, A; Kumar, P | 1 |
| Cormier, K; Del Signore, SJ; Kosaras, B; Kowall, NW; Lee, J; McKee, A; Ratan, RR; Ryu, H | 1 |
2 other study(ies) available for thiazolyl blue and Huntington Disease
| Article | Year |
|---|---|
Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Carotenoids; Catalase; Coloring Agents; Electron Transport Complex IV; Huntington Disease; Lipid Peroxidation; Lycopene; Male; Motor Activity; NADH Dehydrogenase; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotoxins; Nitric Oxide; Nitrites; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar; Signal Transduction; Succinate Dehydrogenase; Superoxide Dismutase; Tetrazolium Salts; Thiazoles | 2009 |
Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice.
Topics: Adenosine Triphosphate; Age Factors; Aldehydes; Analysis of Variance; Animals; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Glutamic Acid; Humans; Huntingtin Protein; Huntington Disease; Imaging, Three-Dimensional; In Situ Nick-End Labeling; Indoles; Lipid Peroxidation; Lipoxygenase Inhibitors; Male; Masoprocol; Membrane Potential, Mitochondrial; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Mitochondria; Neostriatum; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Oxidative Stress; Synapses; Tetrazolium Salts; Thiazoles; Trinucleotide Repeat Expansion | 2011 |